UCSF Vascular Symposium 2018 April 19-21, 2018 Parc55 San Francisco - - PDF document
Department of Surgery, Division of Vascular and Endovascular Surgery, University of California, San Francisco School of Medicine presents UCSF Vascular Symposium 2018 April 19-21, 2018 Parc55 San Francisco San Francisco, CA COURSE CHAIR
Department of Surgery, Division of Vascular and Endovascular Surgery, University of California, San Francisco School of Medicine presents
April 19-21, 2018 Parc55 San Francisco San Francisco, CA COURSE CHAIR Michael S. Conte, MD COURSE CO-CHAIRS Charles Eichler, MD Alexander Reyzelman, DPM University of California, San Francisco
University of California, San Francisco School of Medicine
This CME activity was supported in part by educational grants from the following: Abbott Vascular Cook Medical Medtronic Osiris WL Gore
This CME activity was supported in part by In-Kind Support from the following: Medtronic
Abbott Vascular Ademus, Ltd. Argon Medical Devices BD Peripheral Interventions Boston Scientific BTG International, Inc. Cook Medical Cryolife Getinge Gore & Associates KCI (Acelity) Medtronic EndoVascular Medtronic Peripheral Vascular Mimedx Group, Inc Osborn Medical Osiris Therapeutics, Inc. Penumbra, Inc. Pfizer Philips SIEMENS Healthineers Tactile Medical
University of California, San Francisco School of Medicine Presents
Educational Objectives Upon completion of this program, attendees will be able to:
reduce failure rates of peripheral vascular interventions;
ulcers. ACCREDITATION The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Physicians UCSF designates this live activity for a maximum of 21.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This CME activity meets the requirements under California Assembly Bill 1195, Continuing Education and Cultural and Linguistic Competency. Nurses For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME. Physician Assistants AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Pharmacists The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credit™. American Board of Surgery (ABS) MOC: This course includes a self-assessment post-test which assesses your understanding of the material presented. Up to 21.50 CME credits will be approved for self-assessment credit after receiving at least a 75% score on the post-test.
Attendance Verification/Sign-In Sheet / CME Certificates
Please remember to sign-in on the sign-in sheet when you check in at the UCSF Registration Desk on your first day. You only need to sign-in once for the course, when you first check in. After the meeting, you will receive an email from Qualtrics@ucsf.edu with a link to complete your online Course Evaluation/ Electronic CME Certificate. Please make sure that you add this email to your safe senders list. The Qualtrics system will send you reminders to complete your CME Certificate Claiming until you complete it. Upon completing the Electronic CME Certificate, your CME certificate will be automatically generated to print and/or email yourself a copy. For smartphone users, you may want to take a photo of your certificate as some settings prevent you from emailing the certificate. The link will be available for 30 days after the last day of the course. However, after that date the link will expire and you will no longer be able to claim your credits online. You must then contact the Office of CME at registration@ocme.ucsf.edu to receive your certificate and a $15 administrative fee may be applied. Speaker Survey Your opinion is important to us – we do listen! The speaker survey is electronic and was emailed to you the first morning of the conference. Please complete this during the meeting or shortly after the conclusion of the meeting.
Electronic Syllabus
In an effort to minimize our carbon footprint, we began distributing an electronic syllabus in 2010 – doing so saves nearly 400,000 pieces of paper! For the evaluation purposes, please rate the syllabus based on the PowerPoint presentation inside the ballroom. After the conference we will be posting a PDF copy of all the presentations on this website: http://www.ucsfcme.com/2018/MSU18003/info.html
Security
We urge caution with regard to your personal belongings and syllabus books. We are unable to replace these in the event of loss. Please do not leave any personal belongings unattended in the meeting room during lunch or breaks or overnight. Exhibits Industry exhibits will be available outside the ballroom during breakfasts and breaks, and lunches. Final Presentations A link to PDF versions of the final presentations will be sent via e-mail approximately 3 – 4 weeks post course. Only presentations that have been authorized for inclusion by the presenter will be included
Federal and State Law
Regarding Linguistic Access and Services for Limited English Proficient Persons I. Purpose. This document is intended to satisfy the requirements set forth in California Business and Professions code 2190.1. California law requires physicians to obtain training in cultural and linguistic competency as part of their continuing medical education programs. This document and the attachments are intended to provide physicians with an overview of federal and state laws regarding linguistic access and services for limited English proficient (“LEP”) persons. Other federal and state laws not reviewed below also may govern the manner in which physicians and healthcare providers render services for disabled, hearing impaired or other protected categories II. Federal Law – Federal Civil Rights Act of 1964, Executive Order 13166, August 11, 2000, and Department of Health and Human Services (“HHS”) Regulations and LEP Guidance. The Federal Civil Rights Act of 1964, as amended, and HHS regulations require recipients of federal financial assistance (“Recipients”) to take reasonable steps to ensure that LEP persons have meaningful access to federally funded programs and services. Failure to provide LEP individuals with access to federally funded programs and services may constitute national origin discrimination, which may be remedied by federal agency enforcement action. Recipients may include physicians, hospitals, universities and academic medical centers who receive grants, training, equipment, surplus property and other assistance from the federal government. HHS recently issued revised guidance documents for Recipients to ensure that they understand their obligations to provide language assistance services to LEP persons. A copy of HHS’s summary document entitled “Guidance for Federal Financial Assistance Recipients Regarding Title VI and the Prohibition Against National Origin Discrimination Affecting Limited English Proficient Persons – Summary” is available at HHS’s website at: http://www.hhs.gov/ocr/lep/ . As noted above, Recipients generally must provide meaningful access to their programs and services for LEP persons. The rule, however, is a flexible one and HHS recognizes that “reasonable steps” may differ depending on the Recipient’s size and scope of services. HHS advised that Recipients, in designing an LEP program, should conduct an individualized assessment balancing four factors, including: (i) the number or proportion of LEP persons eligible to be served or likely to be encountered by the Recipient; (ii) the frequency with which LEP individuals come into contact with the Recipient’s program; (iii) the nature and importance
resources available to the Recipient and the costs of interpreting and translation services. Based on the Recipient’s analysis, the Recipient should then design an LEP plan based on five recommended steps, including: (i) identifying LEP individuals who may need assistance; (ii) identifying language assistance measures; (iii) training staff; (iv) providing notice to LEP persons; and (v) monitoring and updating the LEP plan. A Recipient’s LEP plan likely will include translating vital documents and providing either on-site interpreters or telephone interpreter services, or using shared interpreting services with other
emergent needs of the LEP individual, such as hiring bilingual staff who are competent in the skills required for medical translation, hiring staff interpreters, or contracting with outside public
examples of the mix of services that a Recipient should consider and implement. HHS’s guidance also establishes a “safe harbor” that Recipients may elect to follow when determining whether vital documents must be translated into other languages. Compliance with the safe harbor will be strong evidence that the Recipient has satisfied its written translation obligations. In addition to reviewing HHS guidance documents, Recipients may contact HHS’s Office for Civil Rights for technical assistance in establishing a reasonable LEP plan.
III. California Law – Dymally-Alatorre Bilingual Services Act. The California legislature enacted the California’s Dymally-Alatorre Bilingual Services Act (Govt. Code 7290 et seq.) in order to ensure that California residents would appropriately receive services from public agencies regardless of the person’s English language skills. California Government Code section 7291 recites this legislative intent as follows: “The Legislature hereby finds and declares that the effective maintenance and development of a free and democratic society depends
with their government and the right and ability of the government to communicate with them. The Legislature further finds and declares that substantial numbers of persons who live, work and pay taxes in this state are unable, either because they do not speak or write English at all, or because their primary language is other than English, effectively to communicate with their government. The Legislature further finds and declares that state and local agency employees frequently are unable to communicate with persons requiring their services because of this language barrier. As a consequence, substantial numbers of persons presently are being denied rights and benefits to which they would
It is the intention of the Legislature in enacting this chapter to provide for effective communication between all levels of government in this state and the people of this state who are precluded from utilizing public services because of language barriers.” The Act generally requires state and local public agencies to provide interpreter and written document translation services in a manner that will ensure that LEP individuals have access to important government services. Agencies may employ bilingual staff, and translate documents into additional languages representing the clientele served by the agency. Public agencies also must conduct a needs assessment survey every two years documenting the items listed in Government Code section 7299.4, and develop an implementation plan every year that documents compliance with the Act. You may access a copy of this law at the following url: http://www.spb.ca.gov/bilingual/dymallyact.htm
Course Chairs
Michael S. Conte, MD Professor of Surgery and Chief, Division of Vascular and Endovascular Surgery Charles Eichler, MD Professor of Surgery, Division of Vascular and Endovascular Surgery Alexander Reyzelman, DPM Associate Physician Diplomate, Division of Vascular and Endovascular Surgery
Course Faculty (University of California, San Francisco unless indicated)
George Andros, MD Medical Director Emeritus, Amputation Prevention Center, Valley Presbyterian Hospital Los Angeles, CA Ehrin J. Armstrong MD MSc Associate Professor of Medicine, University of Colorado; Director, Interventional Cardiology, Denver VA Medical Center David G. Armstrong, DPM, MD, PhD Professor of Surgery; Director, Southwestern Academic Limb Salvage Alliance (SALSA) Division of Vascular Surgery and Endovascular Therapy, University of Southern California Timothy AM Chuter, MD Professor of Surgery, Division of Vascular and Endovascular Surgery Monara Dini, DPM Associate Clinical Professor, Chief, Podiatric Surgery Section ZSFG/UCSF Ronald M. Fairman, M.D. The Clyde F. Barker - William Maul Measey Professor of Surgery Chief, Division of Vascular Surgery and Endovascular Therapy, Vice-Chairman for Clinical Affairs, Department of Surgery Professor of Surgery in Radiology, Hospital of the University of Pennsylvania Warren J. Gasper, MD Chief, Vascular Surgery Section, San Francisco VA Health Care System Assistant Professor of Surgery, Division of Vascular and Endovascular Surgery Patrick J. Geraghty, MD, FACS, RPVI Professor of Surgery and Radiology, Co-Director, Limb Salvage Program, Washington University Medical School Marlene Grenon, MD Associate Professor of Surgery, Division of Vascular and Endovascular Surgery
Sukgu M Han, MD Assistant Professor of Clinical Surgery, Division of Vascular and Endovascular Surgery Co-director, Comprehensive Aortic Center, Keck Medical Center of University of Southern California Jade S. Hiramoto, MD MAS Professor of Surgery, Division of Vascular and Endovascular Surgery Ryan Kohlbrenner, MD Assistant Professor of Clinical Radiology, Interventional Radiology Section
Assistant Professor of Clinical Radiology, Section of Interventional Radiology John R. Laird, MD Medical Director of Adventist Heart and Vascular Institute, Adventist Health, St. Helena, CA John S. Lane, MD Professor of Surgery; Acting Chief, Division of Vascular and Endovascular Surgery, University
Charmaine Lok, MD, MSc, FRCP(C) Medical Director, Hemodialysis & Multi-Care Kidney Clinics, University Health Network Professor of Medicine, University of Toronto, Toronto, Ontario, Canada Joseph V. Lombardi, MD FACS Professor & Chief, Division of Vascular and Endovascular Surgery, Cooper Medical School of Rowan University, Director, Cooper Aortic Center, Camden, NJ Miguel F. Montero-Baker, MD Associate Professor, Division of Vascular Surgery and Endovascular Therapy, Baylor College
Adam Oskowitz, MD Assistant Professor of Surgery, Division of Vascular and Endovascular Surgery Gregory Piazza, MD, MS Assistant Professor of Medicine, Harvard Medical School; Staff Physician Cardiovascular Division, Brigham and Women's Hospital, Boston, MA Joseph H. Rapp, MD Emeritus Professor of Surgery Linda M. Reilly MD Professor of Surgery, Division of Vascular and Endovascular Surgery David Rigberg, MD Professor of Surgery, Program Director, University of California, Los Angeles Russell H. Samson , MD, RVT Clinical Professor of Surgery, Florida State University Medical School Senior Surgeon, Sarasota Vascular Specialists
Rajabrata Sarkar, MD, PhD Barbara Baur Dunlap Professor of Surgery and Physiology; Interim Chair, Department of Surgery; Chief, Division of Vascular Surgery, University of Maryland Baltimore Darren B. Schneider, MD Associate Professor of Surgery; Chief, Division of Vascular and Endovascular Surgery Weill Cornell Medicine, NewYork-Presbyterian Hospital Peter A. Schneider, MD Chief of Vascular Therapy, Hawaii Permanente Medical Group and Kaiser Foundation Hospital Honolulu, Hawaii Ahmed Shalabi, MD, M.Sc Assistant Professor of Anesthesia, Chief of Vascular Anesthesia Shant M. Vartanian, MD Assistant Professor of Surgery, Division of Vascular and Endovascular Surgery
The following individuals have disclosed they have no financial interest/arrangement or affiliation with any commercial interests who provide products or services relating to their presentation(s) in this continuing medical education activity: George Andros, M.D. David G. Armstrong, DPM, MD, PhD Monara Dini, DPM Ronald Fairman, MD Warren J Gasper, MD Marlene Grenon, MD Ryan M Kohlbrenner, MD John S. Lane, III, MD Charmaine Lok, MD, MSc, FRCP(C) Joseph V. Lombardi, MD Adam Oskowitz Joseph H Rapp Linda M Reilly, MD Alexander Reyzelman, DPM Rajabrata Sarkar, MD PhD David M Schneider, MD Ahmed Shalabi, MD. M.Sc. Shant Vartanian, MD The following individuals have disclosed having a financial interest/arrangement or affiliation during the past twelve months with a commercial interest who provides products or services relating to their presentation(s) in this continuing medical education activity. All conflicts of interest have been resolved in accordance with the ACCME Standards for Commercial Support: Name Company Relationship Ehrin Armstrong, MD Abbott Vascular Boston Scientific PhilipsCardiovascular Systems Medtronic Consultant Consultant Consultant Consultant Miguel F Montero-Baker, MD Cook Medical C.R. Bard Medtronic Abbott Vascular Consultant Consultant Consultant Consultant Timothy Chuter Cook Medical Holder of Intellectual Property Rights Michael Conte, MD Abbott Vascular Symic Inc Consultant Consultant Charles Eichler, MD medtronic spine Consultant Patrick Geraghty, MD Bard/Lutonix Boston Scientific Cook Medical Intact Vascular Zimmer Biomet Pulse Therapeutics Grant/Research Support Board Member/ Consultant Grant/Research Support Grant/Research Support/ Consultant Board Member/ Consultant Stock Shareholder (excluding mutual funds) Sukgu Han, MD Cook Medical Gore & Associates Consultant/Honorarium Recipient Consultant/Honorarium Recipient Jade Hiramoto, MD, MAS Cook Grant/Research Support/Holder of Intellectual Property Rights Kanti Pallav Kolli, MD Adient Medical Stock Shareholder (excluding mutual funds) John R Laird, Jr, MD Abbott Vascular Bard Peripheral Vascular Boston Scientific Metronic Syntervention Consultant Consultant Consultant Consultant Stock Shareholder (excluding mutual funds) Gregory Piazza BMS Daiichi Sankyo BTG/EKOS Janssen Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support David Rigberg, MD WL Gore Honorarium Recipient
Russell Samson, MD WL Gore Scanlan Industries Lumedx Panel Member Holder of Intellectual Property Rights Holder of Intellectual Property Rights Peter Schneider Cook Holder of Intellectual Property Rights This UCSF CME educational activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced. This activity has been reviewed and approved by members of the UCSF CME Governing Board in accordance with UCSF CME accreditation policies. Office of CME staff, planners, reviewers, and all
UCSF Vascular Symposium 2018 April 19-21, 2018 THURSDAY, APRIL 19, 2018 7:00 am Registration and Continental Breakfast 8:00 Welcome and Introductions Michael S. Conte, MD ABDOMINAL AORTA • Moderators: Warren Gasper, MD, and John Lane, MD 8:10 Current Guidelines for Management of AAA Warren Gasper, MD 8:30 Step By Step: How I Do EVAR for Ruptured AAA Joseph Lombardi, MD 8:50 What Does the Data Tell Us About Outcomes of EVAR with Challenging Anatomy? Sukgu Han, MD 9:05 The Angulated Neck: I Thought I Could Do This Case, But There is an John Lane, MD Endoleak – Now What? 9:20 EVAR Under Local/Monitored Anesthesia: Should This Be the Standard of Care? Ahmed Shalabi, MD 9:30 Questions 9:45 Coffee Break THORACIC AORTA • Moderators: Linda Reilly, MD, and Ronald Fairman, MD 10:15 Current Guidelines for TAA and Aortic Dissections Darren Schneider, MD 10:35 New Treatments for TBAD: Petticoats, Sac Embolization, and Coils – Do These Joseph Lombardi, MD Really Help or Just Increase Device Cost? 10:50 How to Salvage the Failing TEVAR Darren Schneider, MD 11:05 IMH/Penetrating Ulcers/Saccular Aneurysms: How to Manage and When to Sukgu Han, MD Intervene 11:20 New Technology for Ascending Aorta and Arch Repair: What’s on the Horizon Timothy Chuter, MD 11:30 Binkley Visiting Professorship Lecture: Ronald Fairman, MD 12:00 pm OPTIONAL WORKING LUNCH: Challenging Aortic Cases Moderators: Michael Conte, MD and Ronald Fairman, MD Panel: Timothy Chuter, MD,Sukgu Han,MD, Joseph Lombardi, MD,Darren Schneider, MD CAROTID AND AV ACCESS • Moderators: Charles Eichler, MD, and Joseph Rapp, MD 1:30 Current Guidelines for Treatment of Carotid Artery Disease John Lane, MD 1:45 Transcervical Carotid Stenting: Patient Selection, Techniques, and Results Peter Schneider, MD 1:55 Asymptomatic Carotid Stenosis: with All of the New Drugs, Joseph Rapp, MD Do We Need to Operate on These Patients? 2:10 How I Approach Patients With Both Proximal Common Peter Schneider, MD Carotid and Carotid Bifurcation Disease 2:25
Preliminary Update on the New Vascular Access Guidelines
Charmaine Lok, MD 2:40 Current Management Options for Steal Syndrome John Lane, MD 2:50 DCB for Fistula Salvage: Where Does It Fit in My Algorithm Charles Eichler, MD 3:00 Fistula Failure – How to use risk scores & algorithms Charmaine Lok, MD 3:15 Questions 3:25 Coffee Break THE VASCULAR PRACTICE IN 2018 • Moderators: Jade Hiramoto, MD, and David Rigberg, MD 3:45 Free Standing Angio Suites: How to Balance Productivity, Reimbursement, and David Rigberg, MD Conflict of Interest 4:10 Radiation Safety: How Can We Reduce Risk? Ryan Kohlbrenner, MD 4:35 Branding your Vascular Practice: Principles of Effective Marketing Russell Samson MD 5:00 pm Adjourn
FRIDAY, APRIL 20, 2018 7:30 am Registration and Continental Breakfast CLAUDICATION PART I • Moderators: Marlene Grenon, MD and Ehrin Armstrong, MD 8:00 Guidelines for Treatment of Claudication Patrick Geraghty, MD 8:20 Supervised Exercise Therapy: How to Start a Program Marlene Grenon, MD 8:40 Medical Treatment For Claudication: What Works and What’s on The Horizon? Ehrin Armstrong, MD 9:00 Vascular Imaging in The Claudicant: Are we Doing too Many Tests and Does this Rajabrata Sarkar, MD Promote Invasive Treatment? 9:20 Questions 9:45 Coffee Break CLAUDICATION PART II • Moderators: Shant Vartanian, MD and David Rigberg, MD 10:00 Endovascular Treatment of Aortoiliac Occlusive Disease: What’s in My Toolbox Jade Hiramoto, MD in 2018 10:15 Surgical Treatment of AIOD in 2018: Who Gets It? David Rigberg, MD 10:30 Debate: This is My Approach to Treatment of the Claudicant with Femoral-Popliteal Disease We Are Doing Too Much Interventions Russell Samson, MD We Are Undertreating People with Disability Peter Schneider, MD 11:00 Popliteal/Tibial Interventions: Is It ever Appropriate for Claudication? Miguel Montero-Baker, MD 11:20 Re-Intervention for Claudication: Is This Effective or a Slippery Slope? Patrick Geraghty, MD 11:40 Questions 12:00 pm OPTIONAL WORKING LUNCH: Challenging Claudication Cases Moderator: Patrick Geraghty, MD/Rajabrata Sarkar, MD, PhD Panel: David Rigberg, MD /Russell Samson, MD /Peter Schneider, MD/Shant Vartanian, MD VENOUS DISEASE • Adam Oskowitz, MD, PhD and Rajabrata Sarkar, MD, PhD 1:15 Current Guidelines for the Treatment of Acute DVT Rajabrata Sarkar, MD, PhD 1:30 Debate: Acute DVT: We Can Expand Our Indications to Treat More Patients with the New Thrombectomy Devices Pro Kanti Kolli, MD Con Gregory Piazza, MD 1:50 How Do We Evaluate and When Do We Treat Iliac Venous Disease? Adam Oskowitz, MD, PhD 2:10 With All the New Drugs, This is How I Treat Acute DVT and Superficial Phlebitis Gregory Piazza, MD 2:30 Clinical Scenarios in Venous Disease: Consults for the Panel Moderator: Charles Eichler, MD Panel: Kanti Kolli, MD/Adam Oskowitz, MD, PhD/Gregory Piazza, MD/Rajabrata Sarkar, MD, PhD 3:00 Physician Entrepreneurship and Technology Pat Basu, MD 3:30 Coffee Break 3:45 HANDS-ON WORKSHOPS
Warren Gasper, MD
David Rigberg, MD and Shant Vartanian, MD 5:30 pm Course Reception
SATURDAY, APRIL 21, 2018 7:30 am Registration and Continental Breakfast LIMB SALVAGE MINI-SYMPOSIUM 8:00 Limb Salvage Mini-Symposium Welcome and Introductions Michael S. Conte, MD CRITICAL LIMB ISCHEMIA/LIMB SALVAGE I • Moderator: Monara Dini, DPM 8:10 Global Guidelines for the Treatment of Limb Threatening Ischemia Michael S. Conte, MD 8:30 Can This Foot be Saved? Will it be Functional? Monara Dini, DPM Alexander Reyzelman, DPM 8:50 Wound Management in the Diabetic Foot: What Products Are Most Effective?
David Armstrong, DPM, MD, PhD
9:10 Measurement of Perfusion: Current Limitations and Novel Technologies Miguel Montero-Baker, MD 9:30 Understanding Angiosomes in Limb Salvage: How I Use It to Define Treatment Shant Vartanian, MD 9:45 Antibiotics for the Treatment of Osteomyelitis Monara Dini, DPM 10:00 Break LIMB SALVAGE II • Joseph Rapp, MD, and George Andros, MD 10:15 Open Bypass for Limb Salvage: What are the Options When There is No Russell Samson, MD Saphenous Vein 10:35 This is My Approach to the Rx of BTK Disease for CLI Shant Vartanian, MD 10:55 Debate: Atherectomy A Key Component of My Treatment of Patients with CLI John Laird, MD A Waste of Time and Money Patrick Geraghty, MD 11:20 Limb Salvage Mini-Symposium Keynote Address: Global Guidelines for the
David Armstrong, DPM, MD, PhD
Treatment of Diabetic Foot Infection 11:50 Questions 12:00 pm OPTIONAL WORKING LUNCH: Challenging Limb Salvage/Wound Healing Cases Moderators: George Andros, MD/Alexander Reyzelman, DPM Panel: David Armstrong, DPM, MD, PhD/Michael Conte, MD/John Laird, MD/Miguel Montero-Baker, MD LIMB SALVAGE III • Michael Conte, MD, and Alexander Reyzelman, DPM 1:00 Foot Surgery and Revascularization: Optimizing the Sequence and Timing
David Armstrong, DPM, MD, PhD
1:20 Inframalleolar Disease: When and How to Intervene – Does It Really Work? John Laird, MD 1:40 CLI Team: Does It Improve Outcomes or Streamline Care? Ehrin Armstrong, MD 2:00 CLI Team: the UCSF Experience Alexander Reyzelman, DPM 2:15 Questions 2:30 pm Adjourn
June 22-23, 2018 Merchant Exchange Club, San Francisco, California
September 20-21, 2018 InterContinental San Francisco, San Francisco, California
November 2-3, 2018 Vdara Hotel, Las Vegas, Nevada 35th Annual Advances in Heart Disease December 7-9, 2018 JW Marriott San Francisco Union Square, San Francisco, CA
All Courses Managed by: UCSF Office of Continuing Medical Education 3333 California Street, Room 450, San Francisco, CA 94118 For attendee information call: 415-476-4251 For exhibitor information: 415-476-4253 Visit the web site at www.cme.ucsf.edu